Reszon Diagnostics International Sdn. Bhd. (Reszon) successfully exhibited in Medlab Asia 2022, Impact Exhibition Center, Bangkok from 19-21 October 2022.
The new launch of Chembio HIV rapid point-of-care assays has gained interest from world-class traders and industry leaders as well as top-of-the buyers.
“We foresee the enormous potential for Chembio HIV rapid test kit product range and we strive to collaborate with distributors to expand the market reach to local and South East Asia market”, said Ms. Katherine Koay, sales director of Reszon.
Meet Reszon’s sales team in Medlab Asia 2022
Overview of booth at Medlab Asia 2022
Overview of booth at Medlab Asia 2022
0 Likes
